| Overview |
| bsm-30096m-pbs-only-100ul |
| human CD19 Monoclonal Antibody, PBS Only Conjugated |
| FCM |
| Human |
| Specifications |
| PBS Only |
| Mouse |
| KLH conjugated synthetic peptide derived from human CD19 |
| Monoclonal |
| HI19a |
| IgG1 |
| 1ug/ul |
| Purified by Protein G. |
| PBS (pH=7.4) |
| Store at 4°C for 12 months. |
| Target |
| 930 |
| P15391 |
| Antibody deficiency due to defect in CD19, included; AW495831; B lymphocyte antigen CD19; B lymphocyte surface antigen B4; B4; CD 19; CD19 antigen; CD19 molecule; Cd19 protein; Differentiation Antigen CD19; Leu 12; Leu12; Lymphocyte Surface Antigen; MGC109570; MGC12802; T-cell surface antigen Leu-12; CD19_HUMAN. |
CD19 is a transmembrane glycoprotein that is delectively expressed on the cell surface of B-lymphocytes,where it activates intracellular signaling cascades involving both Ras and phosphatidylinositol 3-kinase pathways.Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
|
| Application Dilution |
| FCM |
1ug/Test |
Powered by Bioz